Effect of fish oil supplementation in pregnancy on the fatty acid composition of erythrocyte phospholipids and breast milk lipids

This article refers to:

Effect of fish oil supplementation in pregnancy on the fatty acid composition of erythrocyte phospholipids and breast milk lipids

A column in the Table I was omitted. An error was also made in the Results and discussion on Page 38.

Table I.  Fatty acid composition (g/100 g of total fatty acids) of the erythrocyte membranes, breast milk and serum of the women supplemented with fish oil (n = 7) and primrose oil (n = 4).

	Erythrocyte membrane		Breast milk		Serum
	Fish oil	Fish oil	Fish oil	Primrose oil	Fish oil	Fish oil	Primrose oil	Primrose oil
Fatty acids	T0	T1			T0	T1	T0	T1
14:0	0.3 ± 0.1	0.4 ± 0.2	6.4 ± 2.2	5.9 ± 1.7	2.6 ± 0.6	2.8 ± 0.3	1.0 ± 0.7	2.2 ± 0.1
16:0	22.9 ± 2.6	23.1 ± 0.9	21.9 ± 1.9	21.9 ± 1.5	29.9 ± 4.7	23.9 ± 1.1	29.2 ± 1.3	24.1 ± 3.0
18:0	18.4 ± 2.2	19.6 ± 2.8	4.9 ± 1.8	5.8 ± 0.8	8.4 ± 3.3	9.1 ± 1.9	9.7 ± 1.2	9.9 ± 3.3
ΣSFAs	41.6	43.1	33.2	33.6	40.9	35.8	39.9	36.2
16:1 n-7	0.8 ± 0.6	0.6 ± 0.2	4.5 ± 3.2	3.1 ± 0.7	1.6 ± 2.6	1.1 ± 0.3	1.6 ± 1.4	5.9 ± 0.3
18:1 n-9	12.4 ± 2.9	14.0 ± 3.1	32.7 ± 0.1	34.0 ± 3.7	19.4 ± 2.7	15.4 ± 0.7	19.4 ± 2.0	14.4 ± 3.6
ΣMUFAs	13.2	14.6	37.2	37.1	21.0	16.5	21.0	20.3
18:2 n-6(LA)	12.3 ± 1.5	12.9 ± 1.9	19.4 ± 3.2	23.1 ± 1.3	22.3 ± 4.2	22.3 ± 2.4	20.4 ± 5.0	24.7 ± 3.1
18:3 n-3	tr	tr	2.9 ± 2.3	1.9 ± 0.2	0.5 ± 0.9	0.7 ± 0.4	0.3 ± 0.2	0.4 ± 0.2
20:4 n-6(AA)	11.9 ± 2.9	9.8 ± 3.5	0.45 ± 0.4	0.6 ± 0.2	3.4 ± 1.4	2.6 ± 0.6	1.2 ± 1.0	5.5 ± 1.1*
20:5 n-3(EPA)	0.4 ± 0.1	0.7 ± 0.1***	0.10 ± 0.03	ND	0.5 ± 0.1	1.2 ± 0.3***	0.6 ± 0.1	0.6 ± 0.5
22:6 n-3(DHA)	2.6 ± 0.1	3.3 ± 0.2**	0.14 ± 0.11	0.03 ± 0.09	0.9 ± 0.3	2.1 ± 0.6**	0.2 ± 0.1	0.1 ± 0.4
Σn-6 PUFAs	24.2	22.7	19.85	23.7	25.7	24.9	21.6	30.2
Σn-3 PUFAs	3.1	4.0	3.1	1.93	1.9	4.0	1.1	1.1
n-6/n-3	7.8 ± 1.3	5.6 ± 0.9***	6.3 ± 2.1	13.8 ± 2.3***	13.7 ± 1.4	6.2 ± 1.0**	19.6 ± 2.7	27.4 ± 2.8**

Notes: Data are expressed as means ± SD. T₀ = basal period; T₁ = after the period of the study intervention (15 days). tr = traces. SFAs, saturated fatty acids; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids. *p = 0.012, **p = 0.03, ***p = 0.04 compared with T₀ for each supplementation.

The table reports of fatty acid composition of erythrocyte membrane, breast milk as well as the serum of the women. This revision does not alter the interpretation of the data presented.

The authors apologise for any inconvenience this may have caused.

The corrected Table and sentence is provided below:

The results and discussion section on page 38 currently reads:

The sum of n-3 PUFA (EPA + DHA + LA) in erythrocyte phospholipids was significantly higher (4.0 g/100 g of total fatty acids) in pregnant mothers supplemented with FO, resulting in a significant reduction in the n-6/n-3 PUFA ratio.

It should read:

The sum of n-3 PUFA (EPA + DHA) in erythrocyte phospholipids was significantly higher (4.0 g/100 g of total fatty acids) in pregnant mothers supplemented with FO, resulting in a significant reduction in the n-6/n-3 PUFA ratio.

Notes

The publisher would like to apologise for an error that occured in International Journal of Food Sciences and Nutrition, February 2012; 63(1): 36–40.